Published in Int J Biochem Cell Biol on June 20, 2008
A Novel Collagen Matricryptin Reduces Left Ventricular Dilation Post-Myocardial Infarction by Promoting Scar Formation and Angiogenesis. J Am Coll Cardiol (2015) 1.55
Host matrix modulation by tumor exosomes promotes motility and invasiveness. Neoplasia (2013) 1.14
Human platelet-rich plasma- and extracellular matrix-derived peptides promote impaired cutaneous wound healing in vivo. PLoS One (2012) 1.12
Propolis modulates vitronectin, laminin, and heparan sulfate/heparin expression during experimental burn healing. J Zhejiang Univ Sci B (2012) 0.99
Laminin-111: a potential therapeutic agent for Duchenne muscular dystrophy. Mol Ther (2010) 0.98
Inflammation modulates expression of laminin in the central nervous system following ischemic injury. J Neuroinflammation (2012) 0.98
Calcium mobilization triggered by the chemokine CXCL12 regulates migration in wounded intestinal epithelial monolayers. J Biol Chem (2010) 0.90
Role of whole bone marrow, whole bone marrow cultured cells, and mesenchymal stem cells in chronic wound healing. Stem Cell Res Ther (2015) 0.84
Laminins: Roles and Utility in Wound Repair. Adv Wound Care (New Rochelle) (2015) 0.81
Exosomal tetraspanins mediate cancer metastasis by altering host microenvironment. Oncotarget (2017) 0.75
Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science (1997) 4.83
A simplified laminin nomenclature. Matrix Biol (2005) 3.81
Pathophysiology of acute wound healing. Clin Dermatol (2007) 2.99
Adhesive recognition sequences. J Biol Chem (1991) 2.38
Matrix metalloproteinases (MMPs) and their physiological inhibitors (TIMPs) are differentially expressed during excisional skin wound repair. Exp Cell Res (1998) 2.01
Processing of laminin-5 and its functional consequences: role of plasmin and tissue-type plasminogen activator. J Cell Biol (1998) 2.00
Deposition of laminin 5 in epidermal wounds regulates integrin signaling and adhesion. Curr Opin Cell Biol (2000) 1.82
Domains of laminin with growth-factor activity. Cell (1989) 1.75
Platelet-derived growth factor (BB homodimer), transforming growth factor-beta 1, and basic fibroblast growth factor in dermal wound healing. Neovessel and matrix formation and cessation of repair. Am J Pathol (1992) 1.72
Recombinant human platelet-derived growth factor-BB for the treatment of chronic pressure ulcers. Ann Plast Surg (1992) 1.67
Clinical evaluation of recombinant human platelet-derived growth factor for the treatment of lower extremity diabetic ulcers. Diabetic Ulcer Study Group. J Vasc Surg (1995) 1.63
Wound repair, keratinocyte activation and integrin modulation. J Cell Sci (1992) 1.60
Efficacy and safety of becaplermin (recombinant human platelet-derived growth factor-BB) in patients with nonhealing, lower extremity diabetic ulcers: a combined analysis of four randomized studies. Wound Repair Regen (1999) 1.60
Differential expression of matrix metalloproteinases and their tissue-derived inhibitors in cutaneous wound repair. Plast Reconstr Surg (2000) 1.51
Expression of matrix metalloproteinases during rat skin wound healing: evidence that membrane type-1 matrix metalloproteinase is a stromal activator of pro-gelatinase A. J Cell Biol (1997) 1.49
Thymosin beta 4 stimulates directional migration of human umbilical vein endothelial cells. FASEB J (1997) 1.46
Expression and biological role of laminin-1. Matrix Biol (2003) 1.45
Extracellular matrix signaling through growth factor receptors during wound healing. Wound Repair Regen (2004) 1.39
Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst (1992) 1.38
Identification of laminin alpha1 and beta1 chain peptides active for endothelial cell adhesion, tube formation, and aortic sprouting. FASEB J (1999) 1.26
Cellular interaction of integrin alpha3beta1 with laminin 5 promotes gap junctional communication. J Cell Biol (1998) 1.22
The laminins. Int J Biochem Cell Biol (1996) 1.14
Matrikines and matricryptins: Implications for cutaneous cancers and skin repair. J Dermatol Sci (2005) 1.11
Becaplermin gel in the treatment of pressure ulcers: a phase II randomized, double-blind, placebo-controlled study. Wound Repair Regen (1999) 1.07
Temporal study of the activity of matrix metalloproteinases and their endogenous inhibitors during wound healing. J Cell Biochem (1996) 1.06
Photocrosslinkable chitosan hydrogel containing fibroblast growth factor-2 stimulates wound healing in healing-impaired db/db mice. Biomaterials (2003) 1.03
Preclinical promise of becaplermin (rhPDGF-BB) in wound healing. Am J Surg (1998) 1.02
Increase of laminin 5 synthesis in human keratinocytes by acute wound fluid, inflammatory cytokines and growth factors, and lysophospholipids. Br J Dermatol (2004) 1.02
Temporal expression of urokinase plasminogen activator, plasminogen activator inhibitor and gelatinase-B in chronic wound fluid switches from a chronic to acute wound profile with progression to healing. Wound Repair Regen (1999) 1.01
Identification of endothelial cell binding sites on the laminin gamma 1 chain. Circ Res (1999) 0.99
Initiation of skin basement membrane formation at the epidermo-dermal interface involves assembly of laminins through binding to cell membrane receptors. J Cell Sci (1998) 0.95
The laminins: a family of basement membrane glycoproteins important in cell differentiation and tumor metastases. Vitam Horm (1993) 0.93
Thymosin alpha 1 stimulates endothelial cell migration, angiogenesis, and wound healing. J Immunol (1998) 0.87
Human skin basement membrane in health and in autoimmune diseases. Front Biosci (1997) 0.87
Enhanced wound healing in animal models by interferon and an interferon inducer. J Cell Physiol (1992) 0.87
Chimeric VEGF-ENZ7/PlGF specifically binding to VEGFR-2 accelerates skin wound healing via enhancement of neovascularization. Arterioscler Thromb Vasc Biol (2006) 0.86
Platelet-derived growth factor and inflammatory cytokines have differential effects on the expression of integrins alpha 1 beta 1 and alpha 5 beta 1 by human dermal fibroblasts in vitro. J Cell Physiol (1996) 0.86
Topical application of laminin-332 to diabetic mouse wounds. J Dermatol Sci (2007) 0.84
Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp Cell Res (2003) 0.83
Laminin in neural development. Pharmacol Ther (1992) 0.81
Enhanced biosynthesis of extracellular matrix proteins and TGF-beta 1 by polyinosinic-polycytidylic acid during cutaneous wound healing in vivo. J Cell Physiol (1996) 0.78
Role of platelet-derived growth factor as an adjunct to surgery in the management of pressure ulcers. Plast Reconstr Surg (2000) 0.78
[Effect of fibroblasts, collagen, and laminin on the healing of wounds formed after dissection of split skin flaps in rats]. Biull Eksp Biol Med (1997) 0.78
A simplified laminin nomenclature. Matrix Biol (2005) 3.81
In vitro angiogenesis: endothelial cell tube formation on gelled basement membrane extract. Nat Protoc (2010) 2.71
The endothelial cell tube formation assay on basement membrane turns 20: state of the science and the art. Angiogenesis (2009) 2.67
The antifungal drug ciclopirox inhibits deoxyhypusine and proline hydroxylation, endothelial cell growth and angiogenesis in vitro. Int J Cancer (2002) 2.56
Role of thymosin beta4 in tumor metastasis and angiogenesis. J Natl Cancer Inst (2003) 2.23
Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin. Cancer Res (2002) 1.73
The basement membrane matrix in malignancy. J Pathol (2003) 1.69
Gene expression profiles of mouse submandibular gland development: FGFR1 regulates branching morphogenesis in vitro through BMP- and FGF-dependent mechanisms. Development (2002) 1.62
Thymosin beta4: actin-sequestering protein moonlights to repair injured tissues. Trends Mol Med (2005) 1.56
Cell-cell and cell-extracellular matrix interactions regulate embryonic stem cell differentiation. Stem Cells (2007) 1.41
Neuropeptide Y induces migration, proliferation, and tube formation of endothelial cells bimodally via Y1, Y2, and Y5 receptors. FASEB J (2006) 1.33
Complex extracellular matrices promote tissue-specific stem cell differentiation. Stem Cells (2005) 1.31
Estrogens and the vascular endothelium. Ann N Y Acad Sci (2002) 1.31
Multiple uses of basement membrane-like matrix (BME/Matrigel) in vitro and in vivo with cancer cells. Int J Cancer (2011) 1.29
The effects of adrenomedullin overexpression in breast tumor cells. J Natl Cancer Inst (2002) 1.26
The actin binding site on thymosin beta4 promotes angiogenesis. FASEB J (2003) 1.24
An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. J Natl Cancer Inst (2004) 1.24
Slug is a downstream mediator of transforming growth factor-beta1-induced matrix metalloproteinase-9 expression and invasion of oral cancer cells. J Cell Biochem (2009) 1.18
Endogenous osteonectin/SPARC/BM-40 expression inhibits MDA-MB-231 breast cancer cell metastasis. Cancer Res (2005) 1.16
Thymosin beta4 increases hair growth by activation of hair follicle stem cells. FASEB J (2003) 1.10
Regulation of heparanase gene expression by estrogen in breast cancer. Cancer Res (2003) 1.09
Bone marrow-derived cathepsin K cleaves SPARC in bone metastasis. Am J Pathol (2009) 1.08
Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther (2011) 1.07
Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms. Oncogene (2005) 1.00
Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Invest Ophthalmol Vis Sci (2007) 0.99
Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer. Cancer Res (2008) 0.99
Angiogenic activity of human CC chemokine CCL15 in vitro and in vivo. FEBS Lett (2004) 0.98
Identification of an active site on the laminin alpha5 chain globular domain that binds to CD44 and inhibits malignancy. Cancer Res (2004) 0.98
Heparanase regulates murine hair growth. Am J Pathol (2005) 0.97
Pericyte-like location of GFP-tagged melanoma cells: ex vivo and in vivo studies of extravascular migratory metastasis. Am J Pathol (2004) 0.97
Matrix cell adhesion activation by non-adhesion proteins. J Cell Sci (2005) 0.95
Thymosin beta 4 induces hair growth via stem cell migration and differentiation. Ann N Y Acad Sci (2007) 0.95
Biological activities of homologous loop regions in the laminin alpha chain G domains. J Biol Chem (2003) 0.93
Increased initiation and growth of tumor cell lines, cancer stem cells and biopsy material in mice using basement membrane matrix protein (Cultrex or Matrigel) co-injection. Nat Protoc (2012) 0.92
Thymosin beta 4 stimulates laminin-5 production independent of TGF-beta. Exp Cell Res (2004) 0.90
Thymosin beta 4 and a synthetic peptide containing its actin-binding domain promote dermal wound repair in db/db diabetic mice and in aged mice. Wound Repair Regen (2003) 0.90
Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination. Cancer Microenviron (2014) 0.90
New method for modeling connective-tissue cell migration: improved accuracy on motility parameters. Biophys J (2007) 0.90
Tissue and serum angiogenic activity is associated with low prevalence of ischemic complications in patients with giant-cell arteritis. Circulation (2002) 0.89
Over-expression of thymosin beta 4 promotes abnormal tooth development and stimulation of hair growth. Int J Dev Biol (2010) 0.89
Thymosin beta4 promotes matrix metalloproteinase expression during wound repair. J Cell Physiol (2006) 0.89
Pilot study on "pericytic mimicry" and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface. Cancer Microenviron (2012) 0.89
Thymosin β4 induces the expression of vascular endothelial growth factor (VEGF) in a hypoxia-inducible factor (HIF)-1α-dependent manner. Biochim Biophys Acta (2010) 0.88
Pericytic-like angiotropism of glioma and melanoma cells. Am J Dermatopathol (2002) 0.88
Ile-Lys-Val-Ala-Val (IKVAV)-containing laminin alpha1 chain peptides form amyloid-like fibrils. FEBS Lett (2002) 0.88
Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. Cancer Res (2005) 0.87
Identification of a potent peptide antagonist to an active laminin-1 sequence that blocks angiogenesis and tumor growth. Cancer Res (2003) 0.87
Roles of osteonectin in the migration of breast cancer cells into bone. J Cell Biochem (2006) 0.87
A truncated plasminogen activator inhibitor-1 protein blocks the availability of heparin-binding vascular endothelial growth factor A isoforms. J Biol Chem (2002) 0.87
The B16F10 cell receptor for a metastasis-promoting site on laminin-1 is a heparan sulfate/chondroitin sulfate-containing proteoglycan. Cancer Res (2002) 0.87
Thymosin β4 expression in human tissues and in tumors using tissue microarrays. Appl Immunohistochem Mol Morphol (2011) 0.86
Effects of IL-1 molecules on growth patterns of 3-MCA-induced cell lines: an interplay between immunogenicity and invasive potential. J Immunotoxicol (2010) 0.86
Overexpression of malignancy-associated laminins and laminin receptors by angiotropic human melanoma cells in a chick chorioallantoic membrane model. J Cutan Pathol (2009) 0.85
Basement membrane matrix (BME) has multiple uses with stem cells. Stem Cell Rev (2012) 0.84
Zyxin is upregulated in the nucleus by thymosin beta4 in SiHa cells. Exp Cell Res (2006) 0.84
Integrin-dependent cell behavior on ECM peptide-conjugated chitosan membranes. Biopolymers (2007) 0.83
Could pericytic mimicry represent another type of melanoma cell plasticity with embryonic properties? Pigment Cell Melanoma Res (2013) 0.83
Identification of redundant angiogenic sites in laminin alpha1 and gamma1 chains. Exp Cell Res (2003) 0.83
Covalent surface chemistry gradients for presenting bioactive peptides. Anal Biochem (2007) 0.83
Laminin-111-derived peptides and cancer. Cell Adh Migr (2012) 0.82
Human melanoma cell migration along capillary-like structures in vitro: a new dynamic model for studying extravascular migratory metastasis. J Invest Dermatol (2002) 0.81
Animal studies with thymosin beta, a multifunctional tissue repair and regeneration peptide. Ann N Y Acad Sci (2010) 0.81
Cyclic peptides from the loop region of the laminin alpha 4 chain LG4 module show enhanced biological activity over linear peptides. Biochemistry (2004) 0.81
Laminin-1-derived scrambled peptide AG73T disaggregates laminin-1-induced ovarian cancer cell spheroids and improves the efficacy of cisplatin. Int J Oncol (2008) 0.80
The regenerative peptide thymosin β4 accelerates the rate of dermal healing in preclinical animal models and in patients. Ann N Y Acad Sci (2012) 0.80
The laminin alpha-1 chain derived peptide, AG73, increases fibronectin levels in breast and melanoma cancer cells. Clin Exp Metastasis (2008) 0.80
Angiogenic activity of syndecan-binding laminin peptide AG73 (RKRLQVQLSIRT). Arch Biochem Biophys (2007) 0.79
Effects of isoniazid and niacin on experimental wound-healing. Surgery (2010) 0.79
Advances in the basic and clinical applications of thymosin β4. Expert Opin Biol Ther (2015) 0.78
Metallothionein promotes laminin-1-induced acinar differentiation in vitro and reduces tumor growth in vivo. Cancer Res (2002) 0.78
Angiotropism of human melanoma: studies involving in transit and other cutaneous metastases and the chicken chorioallantoic membrane: implications for extravascular melanoma invasion and metastasis. Am J Dermatopathol (2006) 0.77
Suradista NSC 651016 inhibits the angiogenic activity of CXCL12-stromal cell-derived factor 1alpha. Clin Cancer Res (2002) 0.77
Bifunctional peptides derived from homologous loop regions in the laminin alpha chain LG4 modules interact with both alpha 2 beta 1 integrin and syndecan-2. Biochemistry (2005) 0.76
Thymosin β4 significantly reduces the signs of dryness in a murine controlled adverse environment model of experimental dry eye. Expert Opin Biol Ther (2015) 0.76
The potent peptide antagonist to angiogenesis, C16Y, and cisplatin act synergistically in the down-regulation of the Bcl-2/Bax ratio and the induction of apoptosis in human ovarian cancer cells. Int J Oncol (2011) 0.75
Effect of Dakin's solution on components of a dermal equivalent. J Surg Res (2008) 0.75
Selective side-chain modification of cysteine and arginine residues blocks pathogenic activity of HIV-1-Tat functional peptides. Peptides (2005) 0.75